Business Development

Emergent BioSolutions focuses on developing a robust portfolio of vaccines and therapeutics that fulfill our mission – to protect life. But, developing vaccines and therapeutics can be an expensive and risky proposition.

We use an acquisition and licensing strategy to obtain marketed and development-stage biodefense and commercial product candidates that can provide new or improved methods for activating a prophylactic or therapeutic immune response. We believe this approach enables us to minimize development risks and potentially accelerate commercialization timelines, thereby enabling us to deliver vaccines and therapeutics to the global community.

We have a history of expanding our product portfolio through mutually agreeable acquisitions and licensing
arrangements. To learn more contact us at:
Phone: +01 301-795-6772
E-mail:BD@ebsi.com